Day 2 - starting out with #LBCT 🚀
Elegantly presented by Dr. Ole De Backer from Rigshospitalet - the primary results of the #NOTION2 trial 🫀
More careful patient selection for TAVI in the young? PCRonline 🫀 #EuroPCR
#EuroPCR #JACC LBCT SimPub: #ORBITA -2 symptom-stratified analysis - Although symptom severity & nature were poorly associated with disease severity, the nature of symptoms powerfully predicted the placebo-controlled efficacy of #PCI . bit.ly/3QK76cj
Florentina Simader Rasha Al-Lamee
🎙️NEW #HeartFailure2024 #LBCT Interview 💫Dr Muthu Vaduganathan joins us to discuss findings from the study of four trials investigating the timing of cardio-kidney protection with SGLT2 inhibitors.
📽️Watch here👉 tinyurl.com/5cv6rh2u
📊 #HF events were strikingly modifiable and…
#EuroPCR #JACC LBCT SimPub: Insights from #REVIVED -BCIS2 trial - Completeness of #revascularization , whether anatomical or viability-guided, does not influence outcomes in patients with ischemic #cardiomyopathy . bit.ly/44JRcV0
Saad Ezad Margaret McEntegart Cardiac Research
Soldiers of The Light Brigade train medical skills along side our #NATO Allies, the Lapland Jaeger Battalion, learning how to treat casualties in the High North. 🇫🇮
#strongertogerher #immediateresponse
#ACC24 LBCT IV
ドキソルビシン換算で300mg/m2以上のアントラサイクリン投与された乳がん/リンパ腫患者さんに対するエナラプリルの心筋障害低減効果を評価したPROACT試験はcTnTで評価したprimary endpoint達成せず
GLSやLVEFにも有意な改善効果なし
#PROACTstudy American College of Cardiology
Palak Shah shares #LBCT results #DOAC #LVAD pilot study #THT2024 Time now 4 pivotal RCT on anticoagulation in durable #MCS ? Christopher O'Connor Mitchell Psotka Iyad Isseh إياد نبيل العسّة Mary Looby Inova Schar Heart and Vascular Inova InovaCVfellows
#ACC24 #LBCT AJ Blood, MD, MS presenting the results of DRIVE study that was run by our Accelerator for Clinical Transformation research team. A remote pharmacist and navigator driven program increases SGLT2i and GLP1-RA prescriptions in patients with T2DM. Sim pub Circulation…
ICYMI: Dr. Mikhail Kosiborod shares 🔑 insights from his #JACC LBCT paper, exploring #semaglutide 's impact on the #heartfailure biomarker, #NTproBNP , in patients with #obesity -related #HFpEF . Don't miss the video 👇
📄: bit.ly/4afmmof
#HeartFailure2024 Harlan Krumholz